Rivus Pharmaceuticals

Charlottesville, United States · $167.0M raised

Headquarters
Charlottesville
Employees
11–50
Business Model
B2B
Total Funding
$167.0M
Last Round
$132.0M Series BSep 2022
Rounds
2

About

Rivus Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of cardio-metabolic disease. Its first-in-class small molecule therapy, HU6, is a Controlled Metabolic Accelerator (CMA) that activates mitochondrial uncoupling to address the underlying cause of conditions including type 2 diabetes, hypertension, NASH, and obesity. The company has advanced HU6 through multiple Phase 2 clinical trials and is backed by investors including Medicxi, Longitude Capital, RA Capital Management, and Bain Capital Life Sciences.

Summary

Rivus Pharmaceuticals is a Biotech company based in Charlottesville, United States. It has raised $167.0M in total across 2 rounds, most recently a $132.0M Series B round in Sep 2022. Investors include Longitude Capital, RA Capital Management and Medicxi.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BSep 2022
$132.0M

Sign up to see all 2 rounds

Series A through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Rivus Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/rivus-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/rivus-pharmaceuticals" alt="Rivus Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>